These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12836589)

  • 21. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease.
    Filipović SR; Rothwell JC; van de Warrenburg BP; Bhatia K
    Mov Disord; 2009 Jan; 24(2):246-53. PubMed ID: 18951540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms underlying mirror movements in Parkinson's disease: a transcranial magnetic stimulation study.
    Cincotta M; Borgheresi A; Balestrieri F; Giovannelli F; Ragazzoni A; Vanni P; Benvenuti F; Zaccara G; Ziemann U
    Mov Disord; 2006 Jul; 21(7):1019-25. PubMed ID: 16547917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracortical inhibition of the motor cortex in Segawa disease (DYT5).
    Hanajima R; Nomura Y; Segawa M; Ugawa Y
    Neurology; 2007 Mar; 68(13):1039-44. PubMed ID: 17389309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased cortical excitability with longer duration of Parkinson's disease as evaluated by transcranial magnetic stimulation.
    Bhatia M; Johri S; Behari M
    Neurol India; 2003 Mar; 51(1):13-5. PubMed ID: 12865507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor cortical stimulation for parkinsonism in multiple system atrophy.
    Kleiner-Fisman G; Fisman DN; Kahn FI; Sime E; Lozano AM; Lang AE
    Arch Neurol; 2003 Nov; 60(11):1554-8. PubMed ID: 14623727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical inhibition in Parkinson's disease: new insights from early, untreated patients.
    Cantello R; Tarletti R; Varrasi C; Cecchin M; Monaco F
    Neuroscience; 2007 Nov; 150(1):64-71. PubMed ID: 17964730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemiparkinsonism-hemiatrophy syndrome: neuroradiological and neurophysiological findings.
    Costa B; Zanette G; Bertolasi L; Fiaschi A
    Eur Neurol; 1994; 34(2):107-9. PubMed ID: 8174592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemibody mirror movements in hemiparkinsonism-hemiatrophy syndrome.
    Silvers DS; Menkes DL
    J Neurol Sci; 2009 Dec; 287(1-2):260-3. PubMed ID: 19766249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal cortical excitability in Myoclonus-Dystonia--a TMS study.
    van der Salm SM; van Rootselaar AF; Foncke EM; Koelman JH; Bour LJ; Bhatia KP; Rothwell JC; Tijssen MA
    Exp Neurol; 2009 Apr; 216(2):300-5. PubMed ID: 19118553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation.
    Berardelli A; Rona S; Inghilleri M; Manfredi M
    Brain; 1996 Feb; 119 ( Pt 1)():71-7. PubMed ID: 8624695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.
    Lee WY; Yoon WT; Shin HY; Jeon SH; Rhee PL
    Mov Disord; 2008 Sep; 23(12):1696-700. PubMed ID: 18649391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy.
    Pachatz C; Terracciano C; Desiato MT; Orlacchio A; Mori F; Rocchi C; Bernardi G; Massa R
    Clin Neurophysiol; 2007 Feb; 118(2):262-8. PubMed ID: 17137837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinsonism, dystonia, and hemiatrophy.
    Greene PE; Bressman SB; Ford B; Hyland K
    Mov Disord; 2000 May; 15(3):537-41. PubMed ID: 10830421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up study with repetitive transcranial magnetic stimulation (rTMS) in Parkinson's disease.
    Málly J; Farkas R; Tóthfalusi L; Stone TW
    Brain Res Bull; 2004 Sep; 64(3):259-63. PubMed ID: 15464863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation.
    Eusebio A; Azulay JP; Witjas T; Rico A; Attarian S
    Clin Neurophysiol; 2007 Apr; 118(4):815-23. PubMed ID: 17317305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.
    Montaurier C; Morio B; Bannier S; Derost P; Arnaud P; Brandolini-Bunlon M; Giraudet C; Boirie Y; Durif F
    Brain; 2007 Jul; 130(Pt 7):1808-18. PubMed ID: 17535833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemiparkinsonism-hemiatrophy syndrome.
    Wijemanne S; Jankovic J
    Neurology; 2007 Oct; 69(16):1585-94. PubMed ID: 17938368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcranial magnetic stimulation for differential diagnostics in patients with parkinsonism.
    Morita Y; Osaki Y; Doi Y
    Acta Neurol Scand; 2008 Sep; 118(3):159-63. PubMed ID: 18279482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.